Can a Specific OMT Protocol Influence Patient Pain and Associated Analgesia Use for Primary Headache Disorders?
Can a Specific OMT Protocol Influence Patient-reported Pain and Associated Analgesia Use for Primary Headache Disorders?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Sheldon Yao, D.O
- Phone Number: 516-686-3754
- Email: syao@nyit.edu
Study Locations
-
-
New York
-
Old Westbury, New York, United States, 11545
- Riland Academic Health Care Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 to 75 years of age
- takes opioids or any other pain medication for headaches more than 10 times a month (including over the counter and prescription medications for headaches).
- 3 months or greater history of headaches or migraines
- Patient able to tolerate OMT based on osteopathic physician discretion and with consideration of absolute and relative contraindications to OMT
Exclusion Criteria:
- current diagnosis of neoplasm
- history of headache secondary to trauma or concussion
- history of brain/cranial surgery, cerebral vascular events/disease (e.g., stroke, Brain arteriovenous malformation (AVM), vertebral artery disease)
- acute psychiatric diagnosis
- pregnancy
- history of substance use disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Osteopathic Manipulation arm
|
The active arm will receive osteopathic manipulative treatment which is a hands-on treatment modality use to treat a variety of health concerns.
|
|
Sham Comparator: Sham Light touch arm
|
Sham arm will receive a light touch sham treatment.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain levels
Time Frame: Assessment of weekly average pain from week 1 till week 10 end of the study period
|
The primary outcome measures will assess if consistent use of OMT for headache causes a reduction in headache pain for headache-associated discomfort.
Pain will be rated on a Numeric Rating Scale (NRS) so individuals can rate their pain on a scale from 0 (no pain) to 10 (worst possible pain).
|
Assessment of weekly average pain from week 1 till week 10 end of the study period
|
|
Change in analgesia use
Time Frame: Assessment of weekly amount of pain medications used from week 1 till week 10 end of the study period
|
The primary outcome measures will assess if consistent use of OMT for headache causes a reduction in headache analgesia use for headache-associated discomfort.
|
Assessment of weekly amount of pain medications used from week 1 till week 10 end of the study period
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in quality of Life - Headache disability index
Time Frame: To be completed at Week 1 (initial visit), week 6 (midpoint of study), and week 10 (at completion of study)
|
Secondary measures will assess any changes to physical and mental health and reduce the impact of headaches via the Headache disability index.
Max score = 100.
The higher the score the worse the symptoms.
A 29 point change (95% confidence interval) or greater in the total score from test to retest must occur before the change can be attributed to treatment effects.
|
To be completed at Week 1 (initial visit), week 6 (midpoint of study), and week 10 (at completion of study)
|
|
Change in quality of Life - Headache Impact Test (HIT-6)
Time Frame: To be completed at Week 1 (initial visit), week 6 (midpoint of study), and week 10 (at completion of study)
|
Secondary measures will assess any changes to physical and mental health and reduce the impact of headaches via the Headache Impact Test (HIT-6) Higher scores indicate a greater impact on your life.
Score range 36-78.
|
To be completed at Week 1 (initial visit), week 6 (midpoint of study), and week 10 (at completion of study)
|
|
Change in quality of Life - The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group (EQ-5DL)
Time Frame: To be completed at Week 1 (initial visit), week 6 (midpoint of study), and week 10 (at completion of study)
|
Secondary measures will assess any changes to physical and mental health and reduce the impact of headaches via EQ-5DL - quality of life measure.
5 questions rated on levels with 5 being the highest level of disability and an additional questions on overall health rated on a scale of 100 with 100 being the best possible health and 0 being being the worst possible health.
|
To be completed at Week 1 (initial visit), week 6 (midpoint of study), and week 10 (at completion of study)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Sheldon Yao, D.O, New York Institute of Technology
Publications and helpful links
General Publications
- Jara Silva CE, Joseph AM, Khatib M, Knafo J, Karas M, Krupa K, Rivera B, Macia A, Madhu B, McMillan M, Burtch J, Quinonez J, Albert T, Khanna D. Osteopathic Manipulative Treatment and the Management of Headaches: A Scoping Review. Cureus. 2022 Aug 9;14(8):e27830. doi: 10.7759/cureus.27830. eCollection 2022 Aug.
- Chin J, Qiu W, Lomiguen CM, Volokitin M. Osteopathic Manipulative Treatment in Tension Headaches. Cureus. 2020 Dec 12;12(12):e12040. doi: 10.7759/cureus.12040.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Headache OMT
- BHS-1852 (Other Identifier: New York Institute of Technology BHS-IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.